Insider Ledger
Liquidia Corp (LQDA) insider buying and SEC filings
Liquidia Corp · CIK 1819576
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$318K
Insiders who bought
1
Sold (not marked 10b5-1)
$146.7M
Planned sales (10b5-1)
$76.6M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 26, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 1,581 shares at $43.19 ($68K), marked as a 10b5-1 plan trade. Holdings down 1% to 164,028 shares. | SEC filing Filed Oct 28, 2026, 4:31 PM ET |
| Oct 26, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 688 shares at $43.19 ($30K), marked as a 10b5-1 plan trade. Holdings down <1% to 177,269 shares. | SEC filing Filed Oct 28, 2026, 4:30 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Russell Schundler (General Counsel) sold 13,692 shares at $28.48 ($390K), marked as a 10b5-1 plan trade. Holdings down 2% to 602,841 shares. | SEC filing Filed Oct 13, 2026, 8:05 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Rajeev Saggar (Chief Medical Officer) sold 9,218 shares at $28.48 ($263K), marked as a 10b5-1 plan trade. Holdings down 7% to 126,368 shares. | SEC filing Filed Oct 13, 2026, 8:04 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 8,863 shares at $28.48 ($252K), marked as a 10b5-1 plan trade. Holdings down 5% to 181,487 shares. | SEC filing Filed Oct 13, 2026, 8:03 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 5,245 shares at $28.48 ($149K), marked as a 10b5-1 plan trade. Holdings down 4% to 115,241 shares. | SEC filing Filed Oct 13, 2026, 8:02 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Sanjeev Khindri (Chief Development Officer) sold 1,101 shares at $28.48 ($31K), marked as a 10b5-1 plan trade. Holdings down 2% to 64,846 shares. | SEC filing Filed Oct 13, 2026, 8:01 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 18,938 shares at $28.48 ($539K), marked as a 10b5-1 plan trade. Holdings down 5% to 340,148 shares. | SEC filing Filed Oct 13, 2026, 8:00 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 32,744 shares at $28.48 ($933K), marked as a 10b5-1 plan trade. Holdings down 3% to 1,125,848 shares. | SEC filing Filed Oct 13, 2026, 7:59 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 5,892 shares at $28.48 ($168K), marked as a 10b5-1 plan trade. Holdings down 3% to 165,609 shares. | SEC filing Filed Oct 13, 2026, 7:59 PM ET |
| Oct 12, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 7,301 shares at $28.48 ($208K), marked as a 10b5-1 plan trade. Holdings down 4% to 177,957 shares. | SEC filing Filed Oct 13, 2026, 7:58 PM ET |
| Oct 5, 2026 | Sale | Stephen M Bloch (Director) sold 235,477 shares indirectly at about $27.13 ($6.4M). Indirect holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 7, 2026, 4:30 PM ET |
| Sep 1, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 274 shares at about $67.76 ($19K), marked as a 10b5-1 plan trade. Holdings down <1% to 117,308 shares. | SEC filing Filed Sep 3, 2026 |
| Aug 21, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 73,631 shares at about $69.09 ($5.1M), marked as a 10b5-1 plan trade. Holdings down 30% to 174,606 shares. | SEC filing Filed Aug 25, 2026 |
| Aug 19–20, 2026 | Planned (10b5-1) | Katherine Rielly-Gauvin (Director) sold 55,182 shares between Aug 19 and Aug 20 at about $74.07 ($4.1M), marked as a 10b5-1 plan trade. Holdings down 55% to 44,637 shares. | SEC filing Filed Aug 21, 2026 |
| Aug 17, 2026 | Sale | Rajeev Saggar (Chief Medical Officer) sold 29,534 shares at about $76.84 ($2.3M). Holdings down 17% to 142,265 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 19, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 1,600 shares at $87.53 ($140K), marked as a 10b5-1 plan trade. Holdings down 1% to 167,919 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 27, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 688 shares at $87.53 ($60K), marked as a 10b5-1 plan trade. Holdings down <1% to 216,438 shares. | SEC filing Filed Jul 29, 2026 |
| Jul 22–23, 2026 | Sale | Stephen M Bloch (Director) sold 200,000 shares indirectly between Jul 22 and Jul 23 at about $88.93 ($17.8M). Indirect holdings down 29% to 501,477 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 24, 2026 |
| Jul 20–21, 2026 | Sale | Stephen M Bloch (Director) sold 78,596 shares indirectly between Jul 20 and Jul 21 at about $79.97 ($6.3M). Indirect holdings down 10% to 701,477 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 22, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Sanjeev Khindri (Chief Development Officer) sold 1,185 shares at about $71.51 ($85K), marked as a 10b5-1 plan trade. Holdings down 2% to 65,947 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 7,864 shares at about $71.51 ($562K), marked as a 10b5-1 plan trade. Holdings down 6% to 117,178 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 20,430 shares at about $71.51 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 6% to 345,805 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 35,249 shares at about $71.51 ($2.5M), marked as a 10b5-1 plan trade. Holdings down 3% to 1,130,426 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 7,863 shares at about $71.51 ($562K), marked as a 10b5-1 plan trade. Holdings down 3% to 217,126 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Russell Schundler (General Counsel) sold 14,738 shares at about $71.51 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 2% to 605,962 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Rajeev Saggar (Chief Medical Officer) sold 9,926 shares at about $71.51 ($710K), marked as a 10b5-1 plan trade. Holdings down 5% to 171,799 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 9,539 shares at about $71.51 ($682K), marked as a 10b5-1 plan trade. Holdings down 5% to 182,485 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 13, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 9,002 shares at about $71.51 ($644K), marked as a 10b5-1 plan trade. Holdings down 5% to 169,519 shares. | SEC filing Filed Jul 14, 2026 |
| Jul 6–7, 2026 | Sale | Stephen M Bloch (Director) sold 75,000 shares indirectly between Jul 6 and Jul 7 at about $80.68 ($6.1M). Indirect holdings down 9% to 780,073 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 8, 2026 |
| Jul 1, 2026 | Sale | Stephen M Bloch (Director) sold 25,000 shares indirectly at about $79.47 ($2.0M). Indirect holdings down 3% to 855,073 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jun 22, 2026 | Sale | Stephen M Bloch (Director) sold 100,000 shares indirectly at about $75.74 ($7.6M). Indirect holdings down 10% to 880,073 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 24, 2026 |
| Jun 12–15, 2026 | Sale | Stephen M Bloch (Director) sold 196,111 shares indirectly between Jun 12 and Jun 15 at about $71.45 ($14.0M). Indirect holdings down 17% to 980,073 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 16, 2026 |
| Jun 11, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 24,880 shares at about $70.28 ($1.7M), marked as a 10b5-1 plan trade. Holdings down 17% to 121,863 shares. | SEC filing Filed Jun 15, 2026 |
| Jun 10–11, 2026 | Sale | Stephen M Bloch (Director) sold 388,223 shares indirectly between Jun 10 and Jun 11 at about $68.61 ($26.6M). Indirect holdings down 25% to 1,176,184 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 12, 2026 |
| Jun 8, 2026 | Planned (10b5-1) | Sanjeev Khindri (Chief Development Officer) sold 4,134 shares at $65.46 ($271K), marked as a 10b5-1 plan trade. Holdings down 6% to 67,132 shares. | SEC filing Filed Jun 10, 2026 |
| Jun 8–9, 2026 | Sale | Stephen M Bloch (Director) sold 220,835 shares indirectly between Jun 8 and Jun 9 at about $64.63 ($14.3M). Indirect holdings down 12% to 1,564,407 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 10, 2026 |
| Jun 4, 2026 | Sale | Paul B Manning (Director) sold 200,000 shares indirectly at about $63.91 ($12.8M). Indirect holdings down 20% to 798,335 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 8, 2026 |
| Jun 4–5, 2026 | Sale | Stephen M Bloch (Director) sold 84,800 shares indirectly between Jun 4 and Jun 5 at about $64.95 ($5.5M). Indirect holdings down 5% to 1,785,242 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 8, 2026 |
| Jun 1, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 276 shares at $60.87 ($17K), marked as a 10b5-1 plan trade. Holdings down <1% to 146,743 shares. | SEC filing Filed Jun 3, 2026 |
| Jun 1–3, 2026 | Sale | Arthur S. Kirsch (Director) sold 30,000 shares indirectly (by trust) between Jun 1 and Jun 3 at about $57.71 ($1.7M). Holdings by trust down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 27, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 6,428 shares indirectly at about $62.18 ($400K), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 1,041,667 shares. | SEC filing Filed May 28, 2026 |
| May 21–26, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 75,000 shares indirectly between May 21 and May 26 at about $61.01 ($4.6M), marked as a 10b5-1 plan trade. Indirect holdings down 7% to 1,048,095 shares. | SEC filing Filed May 26, 2026 |
| May 19, 2026 | Sale | David Edward Johnson (Director and 10% owner) sold 5,300 shares indirectly at $59.98 ($318K). Indirect holdings down <1% to 8,133,651 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed May 20, 2026 |
| May 19, 2026 | Purchase (code P) | David Edward Johnson (Director and 10% owner) bought 5,300 shares indirectly at $59.98 ($318K), reported as a purchase (code P). Indirect holdings up <1% to 8,138,951 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 1 other reporting owner. | SEC filing Filed May 20, 2026 |
| May 18–20, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 75,000 shares indirectly between May 18 and May 20 at about $58.91 ($4.4M), marked as a 10b5-1 plan trade. Indirect holdings down 6% to 1,123,095 shares. | SEC filing Filed May 20, 2026 |
| May 13–15, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 75,000 shares indirectly between May 13 and May 15 at about $57.32 ($4.3M), marked as a 10b5-1 plan trade. Indirect holdings down 6% to 1,198,095 shares. | SEC filing Filed May 15, 2026 |
| May 11, 2026 | Sale | Stephen M Bloch (Director) sold 318,893 shares indirectly at about $50.23 ($16.0M). Indirect holdings down 15% to 1,870,042 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 13, 2026 |
| May 8–12, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 75,000 shares indirectly between May 8 and May 12 at about $45.89 ($3.4M), marked as a 10b5-1 plan trade. Indirect holdings down 6% to 1,273,095 shares. | SEC filing Filed May 12, 2026 |
| May 5–7, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 75,000 shares indirectly between May 5 and May 7 at about $40.99 ($3.1M), marked as a 10b5-1 plan trade. Indirect holdings down 5% to 1,348,095 shares. | SEC filing Filed May 7, 2026 |
| Apr 27, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 1,576 shares at $37.78 ($60K), marked as a 10b5-1 plan trade. Holdings down 1% to 175,342 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 27, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 688 shares at $41.65 ($29K), marked as a 10b5-1 plan trade. Holdings down <1% to 214,738 shares. | SEC filing Filed Apr 29, 2026 |
| Apr 17, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 18,839 shares indirectly at about $40.60 ($765K), marked as a 10b5-1 plan trade. Indirect holdings down 1% to 1,423,095 shares. | SEC filing Filed Apr 21, 2026 |
| Apr 14–16, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 53,300 shares indirectly between Apr 14 and Apr 16 at about $40.21 ($2.1M), marked as a 10b5-1 plan trade. Indirect holdings down 4% to 1,441,934 shares. | SEC filing Filed Apr 16, 2026 |
| Apr 14–15, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 142,390 shares between Apr 14 and Apr 15 at about $40.14 ($5.7M), marked as a 10b5-1 plan trade. Holdings down 29% to 353,356 shares. | SEC filing Filed Apr 16, 2026 |
| Apr 13, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 10,547 shares at about $38.34 ($404K), marked as a 10b5-1 plan trade. Holdings down 5% to 184,558 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 13, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 7,301 shares at $38.37 ($280K), marked as a 10b5-1 plan trade. Holdings down 3% to 215,426 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 13, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 5,101 shares at $38.37 ($196K), marked as a 10b5-1 plan trade. Holdings down 3% to 176,918 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 10–13, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 42,779 shares between Apr 10 and Apr 13 at about $39.36 ($1.7M), marked as a 10b5-1 plan trade. Holdings down 10% to 405,775 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 13, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 4,557 shares at $38.37 ($175K), marked as a 10b5-1 plan trade. Holdings down 3% to 147,019 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 13, 2026 | Planned (10b5-1) | Rajeev Saggar (Chief Medical Officer) sold 9,220 shares at $38.37 ($354K), marked as a 10b5-1 plan trade. Holdings down 5% to 173,270 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 13, 2026 | Planned (10b5-1) | Russell Schundler (General Counsel) sold 13,692 shares at $38.37 ($525K), marked as a 10b5-1 plan trade. Holdings down 2% to 610,532 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 10–13, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 54,177 shares directly and indirectly between Apr 10 and Apr 13 at about $39.06 ($2.1M), marked as a 10b5-1 plan trade. Direct holdings down 3% to 1,137,599 shares. | SEC filing Filed Apr 14, 2026 |
| Apr 9, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 25,000 shares indirectly at about $40.12 ($1.0M), marked as a 10b5-1 plan trade. Indirect holdings down 2% to 1,516,667 shares. | SEC filing Filed Apr 13, 2026 |
| Apr 9, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 133,789 shares at about $40.24 ($5.4M), marked as a 10b5-1 plan trade. Holdings down 25% to 411,855 shares. | SEC filing Filed Apr 13, 2026 |
| Mar 26–27, 2026 | Sale | Stephen M Bloch (Director) sold 70,234 shares indirectly between Mar 26 and Mar 27 at about $36.08 ($2.5M). Indirect holdings down 3% to 2,188,935 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 30, 2026 |
| Mar 23, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 18,314 shares at about $36.79 ($674K), marked as a 10b5-1 plan trade. Holdings down 9% to 187,640 shares. | SEC filing Filed Mar 25, 2026 |
| Mar 13, 2026 | Sale | Rajeev Saggar (Chief Medical Officer) sold 35,365 shares at about $36.30 ($1.3M). Holdings down 17% to 174,473 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 17, 2026 |
| Mar 13, 2026 | Sale | Sarah Krepp (Chief Human Resource Officer) sold 16,261 shares at $38.00 ($618K). Holdings down 10% to 148,397 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 17, 2026 |
| Mar 9, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 80,000 shares at about $35.32 ($2.8M), marked as a 10b5-1 plan trade. Holdings down 30% to 188,954 shares. | SEC filing Filed Mar 11, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 276 shares at $30.58 ($8K), marked as a 10b5-1 plan trade. Holdings down <1% to 164,658 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 445 shares at $30.58 ($14K), marked as a 10b5-1 plan trade. Holdings down <1% to 178,840 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Russell Schundler (General Counsel) sold 1,073 shares at $30.58 ($33K), marked as a 10b5-1 plan trade. Holdings down <1% to 614,057 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 827 shares at $30.58 ($25K), marked as a 10b5-1 plan trade. Holdings down <1% to 188,954 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 1,165 shares at $30.58 ($36K), marked as a 10b5-1 plan trade. Holdings down <1% to 411,855 shares. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 689 shares at $30.58 ($21K), marked as a 10b5-1 plan trade. Holdings down <1% to 212,479 shares. | SEC filing Filed Mar 3, 2026 |
| Jan 26, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 1,580 shares at $41.65 ($66K), marked as a 10b5-1 plan trade. Holdings down 1% to 178,848 shares. | SEC filing Filed Jan 28, 2026 |
| Jan 26, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 688 shares at $41.65 ($29K), marked as a 10b5-1 plan trade. Holdings down <1% to 211,169 shares. | SEC filing Filed Jan 28, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 13,165 shares at $37.43 ($493K), marked as a 10b5-1 plan trade. Holdings down 9% to 140,769 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 20,533 shares at $37.43 ($769K), marked as a 10b5-1 plan trade. Holdings down 12% to 154,514 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Michael Kaseta (CFO) sold 36,932 shares at $37.43 ($1.4M), marked as a 10b5-1 plan trade. Holdings down 10% to 350,919 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 13,548 shares at $37.43 ($507K), marked as a 10b5-1 plan trade. Holdings down 7% to 184,174 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Russell Schundler (General Counsel) sold 27,289 shares at $37.43 ($1.0M), marked as a 10b5-1 plan trade. Holdings down 4% to 579,394 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Roger Jeffs (CEO and Director) sold 66,610 shares at $37.43 ($2.5M), marked as a 10b5-1 plan trade. Holdings down 6% to 1,037,528 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 11,047 shares at $37.43 ($413K), marked as a 10b5-1 plan trade. Holdings down 7% to 156,700 shares. | SEC filing Filed Jan 13, 2026 |
| Jan 12, 2026 | Planned (10b5-1) | Rajeev Saggar (Chief Medical Officer) sold 21,142 shares at $37.43 ($791K), marked as a 10b5-1 plan trade. Holdings down 11% to 176,883 shares. | SEC filing Filed Jan 13, 2026 |
| Dec 1, 2025 | Planned (10b5-1) | Sarah Krepp (Chief Human Resource Officer) sold 221 shares at $32.19 ($7K), marked as a 10b5-1 plan trade. Holdings down <1% to 141,218 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Dana Boyle (Chief Accounting Officer) sold 303 shares at $32.19 ($10K), marked as a 10b5-1 plan trade. Holdings down <1% to 155,031 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Russell Schundler (General Counsel) sold 1,072 shares at $32.19 ($35K), marked as a 10b5-1 plan trade. Holdings down <1% to 577,288 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Michael Kaseta (CFO) sold 1,166 shares at $32.19 ($38K), marked as a 10b5-1 plan trade. Holdings down <1% to 353,823 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 693 shares at $32.19 ($22K), marked as a 10b5-1 plan trade. Holdings down <1% to 175,868 shares. | SEC filing Filed Dec 2, 2025 |
| Dec 1, 2025 | Planned (10b5-1) | Scott Moomaw (Chief Commercial Officer) sold 831 shares at $32.19 ($27K), marked as a 10b5-1 plan trade. Holdings down 1% to 154,506 shares. | SEC filing Filed Dec 2, 2025 |
| Nov 18, 2025 | Planned (10b5-1) | Jason Adair (Chief Business Officer) sold 35,656 shares at about $30.03 ($1.1M), marked as a 10b5-1 plan trade. Holdings down 17% to 174,998 shares. | SEC filing Filed Nov 20, 2025 |
| Nov 7, 2025 | Sale | Dana Boyle (Chief Accounting Officer) sold 29,004 shares at about $25.09 ($728K). Holdings down 16% to 155,334 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 12, 2025 |
| Nov 5, 2025 | Sale | Rajeev Saggar (Chief Medical Officer) sold 71,381 shares at $27.00 ($1.9M). Holdings down 29% to 176,549 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 7, 2025 |
73 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow LQDA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.